Page last updated: 2024-10-21

abt 702 and Diabetic Retinopathy

abt 702 has been researched along with Diabetic Retinopathy in 1 studies

Diabetic Retinopathy: Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.

Research Excerpts

ExcerptRelevanceReference
"This study was undertaken to determine the effect of an adenosine kinase inhibitor (AKI) in diabetic retinopathy (DR)."7.79ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. ( Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI; Naime, M, 2013)
"This study was undertaken to determine the effect of an adenosine kinase inhibitor (AKI) in diabetic retinopathy (DR)."3.79ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy. ( Ahmad, S; Al-Gayyar, MM; Eissa, LA; El-Shishtawy, MM; Elsherbini, AM; Elsherbiny, NM; Fulzele, S; Liou, GI; Naime, M, 2013)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elsherbiny, NM1
Ahmad, S1
Naime, M1
Elsherbini, AM1
Fulzele, S1
Al-Gayyar, MM1
Eissa, LA1
El-Shishtawy, MM1
Liou, GI1

Other Studies

1 other study available for abt 702 and Diabetic Retinopathy

ArticleYear
ABT-702, an adenosine kinase inhibitor, attenuates inflammation in diabetic retinopathy.
    Life sciences, 2013, Jul-30, Volume: 93, Issue:2-3

    Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine Kinase; Animals; Cells, Cultured; Diabetes M

2013